DrugPatentWatch Database Preview
Epoetin alfa - Biologic Drug Details
» See Plans and Pricing
Summary for epoetin alfa
| Tradenames: | 1 |
| Patents: | 99 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
| Recent Clinical Trials: | See clinical trials for epoetin alfa |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for epoetin alfa |
Recent Clinical Trials for epoetin alfa
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| University College Dublin | Phase 3 |
| Health Research Council, New Zealand | Phase 3 |
| Medical Research Institute of New Zealand | Phase 3 |
Recent Litigation for epoetin alfa
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Ameranth, Inc. v. Starbucks Corporation | 2013-05-06 |
Pharmacology for epoetin alfa
| Ingredient-type | Erythropoietin |
| Physiological Effect | Increased Erythroid Cell Production |
Company Disclosures: US Patents for epoetin alfa
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2012-08-15 | RX | company | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2013-08-20 | RX | company | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2003-12-13 | RX | company | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Amgen Inc. (Thousand Oaks, CA) | 2015-05-26 | RX | company | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2016-09-21 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for epoetin alfa
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | AMGEN INC. (Thousand Oaks, CA) | 2039-02-26 | RX | search | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | 2036-04-01 | RX | search | ||
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | MIDWESTERN UNIVERSITY (Downers Grove, IL) | 2027-08-21 | RX | search | |
| Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | YALE UNIVERSITY (New Haven, CT) | 2039-02-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for epoetin alfa
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 3746785 | Start Trial |
| European Patent Office | 3299346 | Start Trial |
| Russian Federation | 2706146 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2010065496 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006133092 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for epoetin alfa
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2004015 | Lithuania | Start Trial | PRODUCT NAME: DARBEPOETINAS ALFA (ASN30 THR32 VAL87 ASN88 THR90 EPO); REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608 |
| C/GB01/055 | United Kingdom | Start Trial | PRODUCT NAME: DARBEPOETIN ALFA; REGISTERED: UK EU/1/01/185/001-030 20010608 |
| /2007 | Austria | Start Trial | PRODUCT NAME: EPOETIN DELTA; REGISTRATION NO/DATE: EU/1/02/211/001 - EU/1/02/211/009 20020318 |
| C0050 | France | Start Trial | PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608 |
| 0075 | Netherlands | Start Trial | PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
